+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Glycoprotein IIb/IIIa inhibitors in patients with unstable angina/non-ST-segment elevation myocardial infarction: appropriate interpretation of the guidelines



Glycoprotein IIb/IIIa inhibitors in patients with unstable angina/non-ST-segment elevation myocardial infarction: appropriate interpretation of the guidelines



American Heart Journal 146(4 Suppl): S18



In 2002, the American College of Cardiology and the American Heart Association published an update to their guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. These revised guidelines make specific recommendations regarding the use of glycoprotein IIb/IIIa inhibitors. This article briefly reviews the evidence supporting the use of glycoprotein IIb/IIIa inhibitors in unstable angina and non-ST-segment elevation myocardial infarction, before moving on to discuss interpretation of these new guidelines.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 012129926

Download citation: RISBibTeXText

PMID: 14564302

DOI: 10.1016/j.ahj.2003.09.001


Related references

Update: Use of platelet glycoprotein IIb/IIIa inhibitors in patients with unstable angina and non-ST-segment elevation myocardial infarction. Annals of Emergency Medicine 56(5): E1, 2010

Glycoprotein IIb/IIIa inhibitors in unstable angina and non-ST segment elevation myocardial infarction. Coronary Artery Disease 10(8): 561-566, 1999

Evidence-based emergency medicine. Use of platelet glycoprotein IIb/IIIa inhibitors in patients with unstable angina and non-ST-segment elevation myocardial infarction. Annals of Emergency Medicine 40(5): 518-520, 2002

Selection of glycoprotein IIb/IIIa inhibitors for upstream use in patients with diabetes experiencing unstable angina or non-ST segment elevation myocardial infarction. What have we learned in the last 10 years?. Journal of Clinical Pharmacy and Therapeutics 29(6): 497-510, 2004

Use of glycoprotein IIb/IIIa inhibitors in unstable angina and non-ST-elevation myocardial infarction. Emergency Medicine Australasia 17(5-6): 500-510, 2005

Platelet glycoprotein IIb/IIIa blockers for percutaneous coronary revascularization, and unstable angina and non-ST-segment elevation myocardial infarction. Cochrane Database of Systematic Reviews 2001(4): Cd002130, 2001

Glycoprotein IIb/IIIa receptor inhibitor use in unstable angina/non-ST-segment elevation myocardial infarction: an appropriate-use model for the emergency department. Journal of Emergency Medicine 19(3 Suppl): 13s, 2000

Incorporating platelet glycoprotein IIb/IIIa inhibition in critical pathways: unstable angina/non-ST-segment elevation myocardial infarction. Clinical Cardiology 22(8 Suppl): Iv30, 1999

Administration of glycoprotein IIb-IIIa inhibitors in patients with ST-segment elevation myocardial infarction. Pharmacotherapy 22(7): 864-888, 2002

Management of patients with unstable angina and non-ST-segment elevation myocardial infarction: update ACC/AHA guidelines. American Journal of Emergency Medicine 21(4): 346-351, 2003

Comparison of outcomes of patients ≥ 80 years of age having percutaneous coronary intervention according to presentation (stable vs unstable angina pectoris/non-ST-segment elevation myocardial infarction vs ST-segment elevation myocardial infarction). American Journal of Cardiology 108(10): 1395-1400, 2011

Mexican Cardiology Society guidelines for the management of patients with unstable angina and non-ST- segment elevation myocardial infarction. Archivos de Cardiologia de Mexico 72(Supl 2): S5-S44, Octubre-Diciembre, 2002

Early glycoprotein IIb/IIIa inhibitors in patients with non-ST-segment elevation myocardial infarction: Are we ready to open the floodgates?. Journal of the American College of Cardiology 42(1): 54-56, 2003

Glycoprotein IIb/IIIa inhibitors improve mortality after aspiration thrombectomy in patients with ST-segment elevation myocardial infarction. International Journal of Cardiology 187: 206-207, 2015

Coronary artery thrombus in patients with ST-segment elevation myocardial infarction: bad to have it, bad to remove it and a case for glycoprotein IIb/IIIa inhibitors?. Coronary Artery Disease 27(7): 532-534, 2016